US2006204963A1PendingUtilityA1

Nucleotide sequences of coryneform bacteria coding for proteins involved in l-serine metabolism and method for producing l-serine

Assignee: PETERS-WENDISCH PETRAPriority: Mar 13, 2003Filed: Feb 12, 2004Published: Sep 14, 2006
Est. expiryMar 13, 2023(expired)· nominal 20-yr term from priority
C12N 9/88C12P 13/06C12N 15/52C12N 1/20
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to the nucleotide sequences of coryneform bacteria coding for proteins which are involved in L-serine metabolism with reduced and switched off L-serine dehydratase. Said invention also relates to micro-organisms and to methods for producing L-serine.

Claims

exact text as granted — not AI-modified
1 . A nucleic acid which is replicatable in a microorganism of the family Corynebacterium and optionally a recombinant nucleic acid, characterized in that it has a nucleotide sequence coding for L-serine dehydratase which is partially or completely mutated or expressed to a lesser degree than the naturally occurring nucleotide sequence or which is not expressed at all.  
     
     
         2 . A nucleic acid according to  claim 1 , characterized in that the sdaA gene sequence is partially or completely deleted or mutated or expressed to a lesser extent by comparison with the naturally occurring sequence or not expressed at all.  
     
     
         3 . A nucleic acid according to  claim 1 , characterized by a nucleotide sequence according to SEQ ID NO 1 whose nucleotides form position 506 to position 918 are completely or partially deleted or mutated, or an allele, homolog or derivative of this nucleotide sequence or a nucleotide sequence hybridizing therewith.  
     
     
         4 . A nucleic acid according to  claim 1 , characterized in that it is isolated from a  coryneform bacterium.    
     
     
         5 . A nucleic acid according to  claim 1 , characterized in that it is isolated from  Corynebacterium  or  Brevibacterium.    
     
     
         6 . A nucleic acid according to  claim 1 , characterized in that it is isolated from  Corynebacterium glutamicum  or  Brevibacterium flavum.    
     
     
         7 . A gene structure containing at least one nucleotide sequence according to  claim 1  and nucleotide sequences having regulatory sequences operatively linked therewith.  
     
     
         8 . A vector containing at least one nucleotide sequence or a gene structure according to  claim 7  and additional nucleotide sequences for selection, for replication in the host cell or for integration in the host cell genome.  
     
     
         9 . L-serine dehydratase with reduced L-serine dehydratase activity coded with a nucleic acid according to  claim 1 .  
     
     
         10 . L-serine dehydratase according to  claim 9  with an amino acid sequence according to sequence ID 2 whose amino acid are altered in positions 135 to 274 or a modified form of this polypeptide sequence or an isoform thereof.  
     
     
         11 . L-serine dehydratase according to  claim 9 , characterized in that it derives from coryneform bacteria.  
     
     
         12 . L-serine dehydratase according to  claim 9 , characterized in that it derives from coryneform bacteria or brevibacteria.  
     
     
         13 . L-serine dehydratase according to  claim 9 , characterized in that it derives from  Corynebacterium glutamicum  or  Brevibacterium flavum.    
     
     
         14 . A microorganism characterized in that it has a nucleotide sequence which codes for an L-serine dehydratase, which is deleted in whole or in part or is mutated or is expressed to a reduced extent by comparison with the naturally occurring nucleotide sequence or is not expressed at all.  
     
     
         15 . A microorganism according to  claim 14 , characterized in that its sdaA gene is wholly or partially deleted or mutated or to a reduced extent by comparison with the naturally occurring sdaA gene or is not expressed at all.  
     
     
         16 . A microorganism according to containing in replicatable form a nucleic acid according to  claim 1 .  
     
     
         17 . A microorganism according to  claim 14 , characterized in that it is a coryneform bacteria.  
     
     
         18 . A microorganism according to  claim 14 , characterized in that it brings to the family a coryneform bacteria or brevibacteria.  
     
     
         19 . A microorganism according to  claim 14 , characterized in that it brings to the family a  Corynebacterium glutamicum  or  Brevibacterium flavum.    
     
     
         20 . A probe for identifying and/or genes for coding which participate in the biosynthesis of L-serine characterized in that they are produced starting with nucleic acids according to  claim 1  and contain a suitable marker for detection.  
     
     
         21 . A method for the microbial production of L-serine characterized in that 
 (a) a genetically altered microorganism is produced in which the nucleic acid in the microorganism coding for the L-serine dehydratase is partially or completely deleted or mutated or expressed to a reduced extent by comparison with the naturally occurring nucleic acid or is not expressed at all,    (b) this genetically altered microorganism from step (a) is used for microbial production, and    (c) the L-serine formed is isolated from the culture medium.    
     
     
         22 . The method according to  claim 21 , characterized in that the sdaA gene sequence is partially or completely deleted or mutated or expressed to a reduced extent by comparison with the naturally occurring nucleotide sequence or is not expressed at all.  
     
     
         23 . The method according to  claim 21 , characterized in that the nucleotide according to Sequence ID NO 1 is completely or partially deleted or mutated from position 506 to 918 or expressed to a reduced extent by comparison with the naturally occurring nucleotide sequence or not expressed at all.  
     
     
         24 . The method according to  claim 21 , characterized in that a microorganism from the group of  Corynebacterium, Brevibacterium, Arthrobacter, Pseudomonas, Nocardia, Methylobacteria, Hyphomicrobium, Alkaligenes  or  Klebsiella  is used.  
     
     
         25 . A method wherein a nucleic acid according to  claim 1  is used.

Join the waitlist — get patent alerts

Track US2006204963A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.